Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages E1160-E1167

  Daniele, Giuseppe ^a   Gaggini, Melania ^a   Comassi, Mario ^a   Bianchi, Cristina ^a   Basta, Giuseppina ^a   Dardano, Angela ^a   Miccoli, Roberto ^a   Mari, Andrea ^b   Gastaldelli, Amalia ^a   Del Prato, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRACER; TRANSCRIPTION FACTOR 7 LIKE 2; GLUCOSE BLOOD LEVEL; TCF7L2 PROTEIN, HUMAN;

ADULT; ALLELE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HIGH RISK PATIENT; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; METABOLIC PARAMETERS; MIDDLE AGED; MIXED MEAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RATE OF APPEARANCE; RATE OF ENTRY OF MEAL DERIVED EXOGENOUS GLUCOSE INTO THE SYSTEMIC CIRCULATION; TCF7L2 GENE; CLINICAL TRIAL; COHORT ANALYSIS; ENERGY METABOLISM; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; MULTICENTER STUDY; POSTPRANDIAL STATE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; RISK; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84939125175     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1172     Document Type: Article

References (26)

1. Helgason A, Pálsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet. 2007;39:218-225.
2. Zhang C, Qi L, Hunter DJ, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men. Diabetes. 2006;55:2645-2648.
3. Cauchi S, El Achhab Y, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl). 2007;85:777-782.
4. Osmark P, Hansson O, Jonsson A, Rönn T, Groop L, Renström E. Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia. 2009;52:850-854.
5. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469-480.
6. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3β. J Biol Chem. 2005;280:1457-1464.
7. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155-2163.
8. Rosengren AH, Braun M, Mahdi T, et al. Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes. Diabetes. 2012;61:1726-1733.
9. Villareal DT, Robertson H, Bell GI, et al. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes. 2010;59:479-485.
10. Pilgaard K, Jensen CB, Schou JH, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia. 2009;52:1298-1307.
11. Schafer SA, Tschritter O, Machicao F, et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia. 2007;50:2443-2450.
12. Loos RJ, Franks PW, Francis RW, et al. TCF7L2 polymorphisms modulate proinsulin levels and β-cell function in a British Europid population. Diabetes. 2007;56(7):1943-1947.
13. Wegner L, Hussain MS, Pilgaard K, et al. Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins. J Clin Endocrinol Metab. 2008;93:4013-4019.
14. Gjesing AP, Kjems LL, Vestmar MA, et al. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test. Diabetologia. 2011;54:103-110.
15. Smushkin G, Sathananthan M, Sathananthan A, et al. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. Diabetes. 2012;61:1082-1089.
16. Faerch K, Pilgaard K, Knop FK, et al. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele. Diabetes Obes Metab. 2013;15:91-95.
17. Muscelli E, Casolaro A, Gastaldelli A, et al. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012;97:2818-2826.
18. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002;283:E1159-E1166.
19. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41:368-377.
20. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320-323.
21. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011;4:183-187.
22. Modigliani R, Bernier JJ. Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates. Gut. 1971;12:184-193.
23. Fehmann HC, Goke R, Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev. 1995;16:390-410.
24. Neve B, Le Bacquer O, Caron S, et al. Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level. Diabetologia. 2014;57:785-796.
25. Oh KJ, Park J, Kim SS, OH H, Choi CS, Koo SH. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. PLoS Genet. 2012;8(9):e1002986.
26. Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology. 2009;49:426-435.